Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NuVasive
The study is a prospective multi-center randomized evaluation of clinical and radiographic outcomes of two commonly used lumbar interbody fusion procedures (XLIF and TLIF) in adult patients with low-grade symptomatic spondylolisthesis. The study seeks to identify differences between the procedures with respect to perioperative variables.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- Male and female patients who are at least 18 years of age;
\- Patients who present with symptomatic Grade I or II degenerative spondylolisthesis at 1 or 2 contiguous lumbar levels between L1 and L5 and are surgical candidates for interbody lumbar fusion surgery; symptoms should include radiculopathy and/or neurogenic claudication with or without back pain;
\- Patients who have been unresponsive to at least 6 months of conservative treatments or exhibit progressive neurological symptoms in the face of conservative treatment;
\- Patients who understand the conditions of enrollment and are willing to sign an informed consent to participate in the study.
You may not be if
\- Patients with lumbar pathologies requiring treatment at more than 2 levels;
\- Patients who have had previous lumbar fusion surgery;
\- Patients with lytic spondylolisthesis or a defect of the pars interarticularis;
\- Patients with radiographic confirmation of Grade IV facet joint disease or degeneration;
\- Patients with non-contained or extruded herniated nucleus pulposus
